Tizanidine therapy system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11559519
APP PUB NO 20210030724A1
SERIAL NO

16965758

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An object of the present invention is to provide a method for the treatment of a patient suffering from spasticity comprising administering to said patient a modified release dosage form comprising tizanidine or a pharmaceutically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDRX CO LTDHIGASHIKAGAWA-SHI KAGAWA 769-2712

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akazawa, Naoya Higashikagawa, JP 4 6
Hamamoto, Hidetoshi Higashikagawa, JP 69 273
Miwa, Yasushi Higashikagawa, JP 16 25
Tanimoto, Takahiro Higashikagawa, JP 11 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jul 24, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 24, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 24, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00